Ticker

Analyst Price Targets — TRML

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
September 10, 2025 10:06 amYi ChenH.C. Wainwright$48.00$47.61TheFly Tourmaline Bio downgraded to Neutral from Buy at H.C. Wainwright
September 9, 2025 8:09 pmChardan Capital$48.00$47.64TheFly Tourmaline Bio downgraded to Neutral from Buy at Chardan
September 9, 2025 8:07 pmSrikripa DevarakondaTruist Financial$48.00$47.64TheFly Tourmaline Bio downgraded to Hold from Buy at Truist
September 9, 2025 7:16 pmJefferies$47.50$47.64TheFly Tourmaline Bio downgraded to Hold from Buy at Jefferies
September 9, 2025 11:09 amWedbush$48.00$47.64TheFly Tourmaline Bio downgraded to Neutral from Outperform at Wedbush
March 14, 2025 10:05 amH.C. Wainwright$50.00$18.80TheFly Tourmaline Bio price target raised to $50 from $49 at H.C. Wainwright
March 6, 2025 11:57 amWedbush$42.00$14.33TheFly Tourmaline Bio initiated with an Outperform at Wedbush
December 5, 2024 9:12 pmEtzer DaroutBMO Capital$50.00$24.03StreetInsider BMO Capital Starts Tourmaline Bio (TRML) at Outperform
March 21, 2024 9:30 amYatin SunejaGuggenheim$50.00$28.61StreetInsider Guggenheim reiterates Buy rating on Tourmaline Bio (TRML), "news is likely to increase investors' perceived risk"
March 20, 2024 4:42 pmRobyn KarnauskasTruist Financial$74.00$44.67StreetInsider Tourmaline Bio (TRML) PT Raised to $74 at Truist Securities, 'have increased conviction for the opportunity for TOUR006'

No recent news available for TRML.

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for TRML.

No House trades found for TRML.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top